IMPACT BIOMEDICAL INC. - COMMON STOCK (IBO)

CUSIP: 45259L205

Q2 2026 13F Holders as of 30 Jun 2026

Share change
-353
SEC-reported price per share
$0.46
Number of holders
4
Value change
-$212
Number of sells
1

Security key

45259L205

Report period

Q2 2026

Institutions

4

Top holders

4

Ownership snapshot

Top reported holders of IBO - IMPACT BIOMEDICAL INC. - COMMON STOCK (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Chan Heng Fai Ambrose
Disclosed value leader
GEODE CAPITAL MANAGEMENT,...
Comparable rows
1/15
Latest evidence
31 Mar 2026
13D/G 3/4/5 13F Lead comparable stake: 2.9% 14 rows are not safely comparable across share classes. 13D/G row: Chan Heng Fai Ambrose Showing 1-6 of 15 holder rows.

Quick read

Chan Heng Fai Ambrose leads the comparable SEC ownership view at 2.9%.

1 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Chan Heng Fai Ambrose's linked filing trail.
Comparable ownership Top 1
Chan Heng Fai Ambrose 2.9%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Chan Heng Fai Ambrose
13D/G
Heng Fai Ambrose Chan
2.9%
351,555 shares
$0 02 Apr 2025
DSS, INC.
3/4/5
10%+ Owner
class O/S missing
$294,476
545,024 shares
22 May 2025
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
13F
class O/S missing
$716,246
1,192,925 shares
31 Mar 2026
VANGUARD CAPITAL MANAGEMENT LLC
13F
Company
13F
class O/S missing
$424,901
708,168 shares
31 Mar 2026
STATE STREET CORP
13F
Company
13F
class O/S missing
$364,738
607,897 shares
31 Mar 2026
VANGUARD FIDUCIARY TRUST CO
13F
Company
13F
class O/S missing
$351,119
585,198 shares
31 Mar 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
4
Shares
879,661
Rows available
4
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2026 vs Q1 2026 Across Filers

Q1 2026 holders
19
Q2 2026 holders
4
Holder diff
-15
Investor Q1 2026 Shares Q2 2026 Shares Share Diff Share Chg % Q1 2026 value Q2 2026 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .